SLC35A2 Gene

HGNC Family	Solute carriers (SLC)
Name	solute carrier family 35 (UDP-galactose transporter), member A2
Description	This gene encodes a member of the nucleotide-sugar transporter family. The encoded protein is a multi-pass membrane protein. It transports UDP-galactose from the cytosol into Golgi vesicles, where it serves as a glycosyl donor for the generation of glycans. Mutations in this gene cause congenital disorder of glycosylation type IIm (CDG2M). Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Oct 2014]
Summary	{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSLC35A2 encodes a Golgi‐localized UDP‐galactose transporter that supplies UDP‐galactose from the cytosol to the lumen of the Golgi apparatus, a critical step for the proper glycosylation of proteins and lipids. This transporter is essential for the synthesis of galactose‐containing glycan structures, and its proper function is necessary for a host of cellular glycosylation reactions, thereby influencing protein maturation and lipid processing."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "3"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nDefects or mutations in SLC35A2 lead to a unique congenital disorder of glycosylation (CDG) that is often characterized by variable neurological impairments, including early‐onset epileptic encephalopathy. Patients may exhibit abnormal glycosylation profiles—often detected in infancy via biomarkers like transferrin—and a spectrum of clinical features such as developmental delay, hypotonia, and brain malformations. Moreover, somatic mosaicism or de novo mutations in SLC35A2 have been identified in focal malformations of cortical development, further emphasizing its role in neurodevelopment."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "4", "end_ref": "10"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its primary transporter function, SLC35A2 appears to act in concert with other nucleotide sugar transporters and glycosyltransferases to ensure efficient and accurate glycosylation. Studies have demonstrated that SLC35A2 can form heterologous complexes with related transporters (such as the UDP-N-acetylglucosamine transporter) and associate with enzymes involved in both N‐ and O‐glycosylation pathways. Structure–function analyses, including chimeric protein experiments and mutagenesis studies, have identified critical domains and pockets within SLC35A2 that confer substrate specificity and stability, emphasizing the importance of its interactions for proper glycan assembly."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "11", "end_ref": "16"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAlterations in the expression of SLC35A2 have also been implicated in oncogenesis. In certain malignancies, including hepatocellular carcinoma and breast invasive carcinoma, aberrant SLC35A2 expression appears to modulate glycosylation patterns that impact key signaling pathways, such as ERK activation, thereby promoting tumor progression and metastasis. These findings underscore the broader significance of SLC35A2 not only in congenital disorders but also in acquired pathologies like cancer."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "17"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Bobby G Ng, Kati J Buckingham, Kimiyo Raymond, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mosaicism of the UDP-galactose transporter SLC35A2 causes a congenital disorder of glycosylation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajhg.2013.03.012"}], "href": "https://doi.org/10.1016/j.ajhg.2013.03.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23561849"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23561849"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Hirofumi Kodera, Kazuyuki Nakamura, Hitoshi Osaka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "De novo mutations in SLC35A2 encoding a UDP-galactose transporter cause early-onset epileptic encephalopathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mutat (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/humu.22446"}], "href": "https://doi.org/10.1002/humu.22446"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24115232"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24115232"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Bobby G Ng, Paulina Sosicka, Satish Agadi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SLC35A2-CDG: Functional characterization, expanded molecular, clinical, and biochemical phenotypes of 30 unreported Individuals."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mutat (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/humu.23731"}], "href": "https://doi.org/10.1002/humu.23731"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30817854"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30817854"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Mari-Anne Vals, Angel Ashikov, Pilvi Ilves, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clinical, neuroradiological, and biochemical features of SLC35A2-CDG patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Inherit Metab Dis (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jimd.12055"}], "href": "https://doi.org/10.1002/jimd.12055"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30746764"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30746764"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Kristen Westenfield, Kyriakie Sarafoglou, Laura C Speltz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mosaicism of the UDP-Galactose transporter SLC35A2 in a female causing a congenital disorder of glycosylation: a case report."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Med Genet (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12881-018-0617-6"}], "href": "https://doi.org/10.1186/s12881-018-0617-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29907092"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29907092"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Thomas Bonduelle, Till Hartlieb, Sara Baldassari, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Frequent SLC35A2 brain mosaicism in mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Neuropathol Commun (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s40478-020-01085-3"}], "href": "https://doi.org/10.1186/s40478-020-01085-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33407896"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33407896"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Carmen Barba, Ingmar Blumcke, Melodie R Winawer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clinical Features, Neuropathology, and Surgical Outcome in Patients With Refractory Epilepsy and Brain Somatic Variants in the "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "SLC35A2"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " Gene."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurology (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1212/WNL.0000000000201471"}], "href": "https://doi.org/10.1212/WNL.0000000000201471"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36307217"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36307217"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "C H Lang, Y Yang, X Y Niu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[Clinical characteristics of SLC35A2 gene variants related congenital disorders of glycosylation typeⅡ]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Zhonghua Er Ke Za Zhi (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3760/cma.j.cn112140-20200308-00198"}], "href": "https://doi.org/10.3760/cma.j.cn112140-20200308-00198"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32605344"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32605344"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Çiğdem Seher Kasapkara, Ahmet Cevdet Ceylan, Hamit Özyürek, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SLC35A2-CDG: novel variants with two ends of the spectrum."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Pediatr Endocrinol Metab (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1515/jpem-2021-0292"}], "href": "https://doi.org/10.1515/jpem-2021-0292"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34161696"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34161696"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Soad Elziny, Peter B Crino, Melodie Winawer "}, {"type": "b", "children": [{"type": "t", "text": "SLC35A2 somatic variants in drug resistant epilepsy: FCD and MOGHE."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurobiol Dis (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.nbd.2023.106299"}], "href": "https://doi.org/10.1016/j.nbd.2023.106299"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37739137"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37739137"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Dorota Maszczak-Seneczko, Paulina Sosicka, Beata Kaczmarek, et al. "}, {"type": "b", "children": [{"type": "t", "text": "UDP-galactose (SLC35A2) and UDP-N-acetylglucosamine (SLC35A3) Transporters Form Glycosylation-related Complexes with Mannoside Acetylglucosaminyltransferases (Mgats)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M115.636670"}], "href": "https://doi.org/10.1074/jbc.M115.636670"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25944901"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25944901"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Dorota Maszczak-Seneczko, Teresa Olczak, Mariusz Olczak "}, {"type": "b", "children": [{"type": "t", "text": "Subcellular localization of UDP-GlcNAc, UDP-Gal and SLC35B4 transporters."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Biochim Pol (2011)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21918738"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21918738"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Mariusz Olczak, Dorota Maszczak-Seneczko, Paulina Sosicka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "UDP-Gal/UDP-GlcNAc chimeric transporter complements mutation defect in mammalian cells deficient in UDP-Gal transporter."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2013.03.098"}], "href": "https://doi.org/10.1016/j.bbrc.2013.03.098"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23583405"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23583405"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Paulina Sosicka, Piotr Jakimowicz, Teresa Olczak, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Short N-terminal region of UDP-galactose transporter (SLC35A2) is crucial for galactosylation of N-glycans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2014.10.098"}], "href": "https://doi.org/10.1016/j.bbrc.2014.10.098"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25451267"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25451267"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Danyang Li, Somshuvra Mukhopadhyay "}, {"type": "b", "children": [{"type": "t", "text": "A three-pocket model for substrate coordination and selectivity by the nucleotide sugar transporters SLC35A1 and SLC35A2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jbc.2021.101069"}], "href": "https://doi.org/10.1016/j.jbc.2021.101069"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34384782"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34384782"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Wojciech Wiertelak, Karolina Chabowska, Bożena Szulc, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SLC35A2 deficiency reduces protein levels of core 1 β-1,3-galactosyltransferase 1 (C1GalT1) and its chaperone Cosmc and affects their subcellular localization."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta Mol Cell Res (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbamcr.2023.119462"}], "href": "https://doi.org/10.1016/j.bbamcr.2023.119462"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36933771"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36933771"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Hongxia Cheng, Sikai Wang, Dongmei Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nucleotide sugar transporter SLC35A2 is involved in promoting hepatocellular carcinoma metastasis by regulating cellular glycosylation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Oncol (Dordr) (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13402-022-00749-7"}], "href": "https://doi.org/10.1007/s13402-022-00749-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36454514"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36454514"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Xiaochen Yang, Yukai Tao, Yan Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SLC35A2 expression drives breast cancer progression via ERK pathway activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS J (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/febs.17044"}], "href": "https://doi.org/10.1111/febs.17044"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38143314"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38143314"}]}]}]}
Synonyms	UGT1, UGALT, CDG2M, CDGX, UDP-GAL-TR, UGT2, UGTL, UGT
Proteins	S35A2_HUMAN
NCBI Gene ID	7355
API
Download Associations
Predicted Functions
Co-expressed Genes
Expression in Tissues and Cell Lines

Functional Associations

SLC35A2 has 6,209 functional associations with biological entities spanning 8 categories (molecular profile, organism, disease, phenotype or trait, chemical, functional term, phrase or reference, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 108 datasets.

Click the + buttons to view associations for SLC35A2 from the datasets below.

If available, associations are ranked by standardized value

Harmonizome 3.0

SLC35A2 Gene

Functional Associations

Please acknowledge the Harmonizome in your publications by citing the following reference(s):

	Dataset	Summary
	Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles	tissues with high or low expression of SLC35A2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
	Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles	tissue samples with high or low expression of SLC35A2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	tissue samples with high or low expression of SLC35A2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq	tissue samples with high or low expression of SLC35A2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
	Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles	tissues with high or low expression of SLC35A2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
	BioGPS Cell Line Gene Expression Profiles	cell lines with high or low expression of SLC35A2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
	BioGPS Human Cell Type and Tissue Gene Expression Profiles	cell types and tissues with high or low expression of SLC35A2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
	BioGPS Mouse Cell Type and Tissue Gene Expression Profiles	cell types and tissues with high or low expression of SLC35A2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
	CCLE Cell Line Gene CNV Profiles	cell lines with high or low copy number of SLC35A2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
	CCLE Cell Line Gene Expression Profiles	cell lines with high or low expression of SLC35A2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
	CellMarker Gene-Cell Type Associations	cell types associated with SLC35A2 gene from the CellMarker Gene-Cell Type Associations dataset.
	ChEA Transcription Factor Binding Site Profiles	transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC35A2 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
	ChEA Transcription Factor Targets	transcription factors binding the promoter of SLC35A2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
	ChEA Transcription Factor Targets 2022	transcription factors binding the promoter of SLC35A2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
	ClinVar Gene-Phenotype Associations	phenotypes associated with SLC35A2 gene from the curated ClinVar Gene-Phenotype Associations dataset.
	ClinVar Gene-Phenotype Associations 2025	phenotypes associated with SLC35A2 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset.
	CMAP Signatures of Differentially Expressed Genes for Small Molecules	small molecule perturbations changing expression of SLC35A2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
	COMPARTMENTS Curated Protein Localization Evidence Scores	cellular components containing SLC35A2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
	COMPARTMENTS Curated Protein Localization Evidence Scores 2025	cellular components containing SLC35A2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
	COMPARTMENTS Experimental Protein Localization Evidence Scores	cellular components containing SLC35A2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset.
	COMPARTMENTS Experimental Protein Localization Evidence Scores 2025	cellular components containing SLC35A2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset.
	COMPARTMENTS Text-mining Protein Localization Evidence Scores	cellular components co-occuring with SLC35A2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
	COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025	cellular components co-occuring with SLC35A2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
	COSMIC Cell Line Gene CNV Profiles	cell lines with high or low copy number of SLC35A2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
	COSMIC Cell Line Gene Mutation Profiles	cell lines with SLC35A2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
	CTD Gene-Disease Associations	diseases associated with SLC35A2 gene/protein from the curated CTD Gene-Disease Associations dataset.
	DepMap CRISPR Gene Dependency	cell lines with fitness changed by SLC35A2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
	DISEASES Curated Gene-Disease Association Evidence Scores	diseases involving SLC35A2 gene from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset.
	DISEASES Curated Gene-Disease Association Evidence Scores 2025	diseases involving SLC35A2 gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset.
	DISEASES Text-mining Gene-Disease Association Evidence Scores	diseases co-occuring with SLC35A2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	diseases co-occuring with SLC35A2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
	DisGeNET Gene-Disease Associations	diseases associated with SLC35A2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
	DisGeNET Gene-Phenotype Associations	phenotypes associated with SLC35A2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
	ENCODE Histone Modification Site Profiles	histone modification site profiles with high histone modification abundance at SLC35A2 gene from the ENCODE Histone Modification Site Profiles dataset.
	ENCODE Transcription Factor Binding Site Profiles	transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC35A2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
	ENCODE Transcription Factor Targets	transcription factors binding the promoter of SLC35A2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
	ESCAPE Omics Signatures of Genes and Proteins for Stem Cells	PubMedIDs of publications reporting gene signatures containing SLC35A2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
	GDSC Cell Line Gene Expression Profiles	cell lines with high or low expression of SLC35A2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.
	GeneRIF Biological Term Annotations	biological terms co-occuring with SLC35A2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
	GeneSigDB Published Gene Signatures	PubMedIDs of publications reporting gene signatures containing SLC35A2 from the GeneSigDB Published Gene Signatures dataset.